Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12158744 | 1.00 | TSHR (0.57) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL11530697 | 0.89 | MAPT (0.62) | KMT2AMEN1NPC1L3MBTL1MAPT | |
| SCHEMBL963849 | 0.85 | TSHR (0.53) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL14006544 | 0.84 | TSHR (0.57) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL96580 | 0.84 | TSHR (0.57) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL96579 | 0.84 | TSHR (0.57) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL28751184 | 0.84 | MAPT (0.47) | KMT2AMEN1NPC1MAPTALDH1A1 | |
| SCHEMBL8845817 | 0.82 | TSHR (0.55) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL4770344 | 0.82 | GSK3B (0.55) | TSHRKMT2AMEN1NPC1L3MBTL1 | |
| SCHEMBL11650548 | 0.82 | ALDH1A1 (0.55) | TSHRKMT2AMEN1NPC1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4516118-A2 | USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE | Symrise AG (DE) | 2025-03-05 | — | — | EP | claimed |
| EP-4516118-A2 | USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE | Symrise AG (DE) | 2025-03-05 | — | — | EP | disclosed |
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| EP-3665163-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | Symrise AG (DE) | 2020-06-17 | — | — | EP | disclosed |
| US-10336893-B2 | Process for preparing a modified ethylene-based polymer using a hydrocarbon initiator | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-02 | — | — | US | disclosed |
| CN-105754099-B | Composition and polymer | 旭化成株式会社 | 2018-09-18 | — | — | CN | disclosed |
| US-20170362419-A1 | Process for Preparing a Modified Ethylene-Based Polymer Using a Hydrocarbon Initiator | DOW GLOBAL TECHNOLOGIES LLC | 2017-12-21 | — | — | US | disclosed |
| WO-2017174827-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | SYMRISE AG (DE) | 2017-10-12 | — | — | WO | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| EP-2735581-A1 | COMPOSITION AND POLYMER | Asahi Kasei Chemicals Corporation (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20140121293-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| CN-103502315-A | Composition and polymer | ASAHI KASEI CHEMICALS CORP | 2014-01-08 | — | — | CN | disclosed |
| US-20110319386-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS INC. (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110233653-A1 | NON-VOLATILE SEMICONDUCTOR DEVICES AND METHODS OF MANUFACTURING NON-VOLATILE SEMICONDUCTOR DEVICES | LEE HAK-SUN | 2011-09-29 | — | — | US | disclosed |
| US-7594520-B2 | Method of making a dual filter | KING TECHNOLOGY (US) | 2009-09-29 | — | — | US | disclosed |
| EP-0282895-B1 | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMA CO LTD (JP) | 1995-06-07 | — | — | EP | disclosed |
| US-5037976-A | Antimicrobial Agent | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| US-4898859-A | 2-Oxa-isocephem compounds and compositions containing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0282895-A2 | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319386-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | CHRNB2, CHAT, CHRNB4 | TSHR 302/4885KMT2A 1331/4885MEN1 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.